Literature DB >> 31205971

Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013-2017.

Neela D Goswami1, Sundari Mase2, David Griffith3, Rajita Bhavaraju4, Alfred Lardizabal4, Michael Lauzardo5, Lisa Chen6, John Wilson7, Courtney Chappelle1, Connie A Haley5.   

Abstract

With only 9105 new US tuberculosis (TB) cases reported in 2017, expert consultation is essential for TB care. Data were captured 2013-2017 from consultations by 5 CDC-funded centers, now the TB Centers of Excellence (COEs). 14 586 consultations were provided to TB providers, most related to TB disease and treatment regimens.

Entities:  

Keywords:  CDC; Tuberculosis; consultation; medical; national

Year:  2019        PMID： 31205971      PMCID： PMC6499898          DOI： 10.1093/ofid/ofz167

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  5 in total

1.  Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium.

Authors:  Francesco Blasi; Masoud Dara; Marieke J van der Werf; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2013-03       Impact factor: 16.671

2.  The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs.

Authors:  N S Shah; J Westenhouse; P Lowenthal; G Schecter; L True; S Mase; P M Barry; J Flood
Journal:  Public Health Action       Date:  2018-03-21

3.  Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2013-10-25

4.  Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Authors:  David M Lewinsohn; Michael K Leonard; Philip A LoBue; David L Cohn; Charles L Daley; Ed Desmond; Joseph Keane; Deborah A Lewinsohn; Ann M Loeffler; Gerald H Mazurek; Richard J O'Brien; Madhukar Pai; Luca Richeldi; Max Salfinger; Thomas M Shinnick; Timothy R Sterling; David M Warshauer; Gail L Woods
Journal:  Clin Infect Dis       Date:  2017-01-15       Impact factor: 9.079

5.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079
  5 in total
  4 in total

1.  Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings.

Authors:  John W Wilson; Diana M Nilsen; Suzanne M Marks
Journal:  Ann Am Thorac Soc       Date:  2020-01

2.  Challenges in LTBI care in the United States identified using a nationwide TB medical consultation database.

Authors:  N T Agathis; R Bhavaraju; V Shah; L Chen; C A Haley; N D Goswami; A Patrawalla
Journal:  Public Health Action       Date:  2021-09-21

3.  Multidrug-resistant tuberculosis care in the United States.

Authors:  A N Gobaud; C A Haley; J W Wilson; R Bhavaraju; A Lardizabal; B J Seaworth; N D Goswami
Journal:  Int J Tuberc Lung Dis       Date:  2020-04-01       Impact factor: 3.427

4.  Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013-2018.

Authors:  Ashley McDowell; Michelle Haas; Barbara Seaworth; John W Wilson; Amee Patrawalla; Connie Haley; Mike Lauzardo; Miko de Bruyn; Neela D Goswami
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.